India-based Trivitron Healthcare has reinforced its foray into the Middle East market by converting an existing joint venture with ETA Star Healthcare into a wholly-owned subsidiary in Dubai.
The JV with the Al Ghurarir Group company was established in 2006 but Trivitron has now acquired it completely and set up its own offices in Dubai Healthcare City to pursue an aggressive growth plan.
It said in a statement that the move aimed to push its manufactured products in the $80bn Middle East healthcare market.
Trivitron also said that as part of its strategic global growth plan, the company has also acquired Finland-based Anilabsyatem.
Dr GSK Velu, managing director and founder of Trivitron Healthcare said: "We are glad to enter the emerging markets of the world with our own branded products and solutions."
Headquartered in Chennai, Trivitron's products are now exported to over 160 countries and include a range of imaging diagnostics products including ultrasound, X-ray equipment, and an entire range of operating room solutions, and In-Vitro Diagnostics instruments and reagents.